Reply: Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis?

Affiliations

Comment

Jørgen Vestbo et al. Am J Respir Crit Care Med. 2013.

. 2013 Dec 1;188(11):1368.

doi: 10.1164/rccm.201307-1263LE.

¹ 1 University of Manchester Manchester, United Kingdom and University of Southern Denmark Odense, Denmark.

No abstract available

Comment on

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Vestbo J, et al. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.
Phosphodiesterase inhibitors in chronic obstructive pulmonary disease.
Oba Y. Oba Y. Am J Respir Crit Care Med. 2013 Dec 1;188(11):1366. doi: 10.1164/rccm.201303-0510LE. Am J Respir Crit Care Med. 2013. PMID: 24289774 No abstract available.
GOLD Executive Summary.
West JB. West JB. Am J Respir Crit Care Med. 2013 Dec 1;188(11):1366-7. doi: 10.1164/rccm.201304-0743LE. Am J Respir Crit Care Med. 2013. PMID: 24289775 No abstract available.
Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis?
Tzouvelekis A, Siafakas N, Bouros D. Tzouvelekis A, et al. Am J Respir Crit Care Med. 2013 Dec 1;188(11):1367. doi: 10.1164/rccm.201305-0927LE. Am J Respir Crit Care Med. 2013. PMID: 24289776 No abstract available.